secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuwellis, Inc. (NUWE)
CIK:        0001506492
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001140361-24-046009
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuwellis Q3 revenue $2.4M, net income $2.4M; CMS reimbursement up 297%
----------------------------------------------------------------------

- Revenue $2.4M, down 2% YoY; pediatrics revenue grew 28% YoY.
- Gross margin 70% vs 57.3% YoY; operating expenses down 30% YoY.
- Net income attributable to common $2.4M ($1.74/share) vs loss $3.4M; includes $3.9M warrant liability benefit.
- CMS increased Aquadex facility fee reimbursement 297% to $1,639/day, effective Jan 1, 2025.
- Cash $1.9M, no debt; $5.1M gross proceeds from November warrant exercise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506492/000114036124046009/0001140361-24-046009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506492/000114036124046009/ef20038370_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-046009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer